{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-22-000064","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2022-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.207232+00:00","generated_at":"2026-06-23T09:19:12.408188+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Exagen enters $50M ATM equity offering with Cowen and Company","bullets":["Agreement allows Exagen to sell up to $50M of common stock at market prices via Cowen as agent.","Cowen receives 3% commission on gross proceeds; Company not obligated to sell any shares.","Offering terminates upon sale of all shares or termination of the agreement.","Shares sold through Nasdaq Global Market; prospectus supplement filed September 15, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-22-000064","json":"https://secwatch.observer/filing/0001274737-22-000064.json","markdown":"https://secwatch.observer/filing/0001274737-22-000064.md","text":"https://secwatch.observer/filing/0001274737-22-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/0001274737-22-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/exdx-20220915.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:19:12.408188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}